| 臺大學術典藏 |
2022-02-14T07:10:41Z |
Proteogenomics of Non-smoking Lung Cancer in East Asia Delineates Molecular Signatures of Pathogenesis and Progression
|
Chen Y.-J.; Roumeliotis T.I.; Chang Y.-H.; Chen C.-T.; Han C.-L.; Lin M.-H.; Chen H.-W.; Chang G.-C.; YIH-LEONG CHANG; Wu C.-T.; Lin M.-W.; Hsieh M.-S.; Wang Y.-T.; Chen Y.-R.; Jonassen I.; Ghavidel F.Z.; Lin Z.-S.; Lin K.-T.; Chen C.-W.; Sheu P.-Y.; Hung C.-T.; Huang K.-C.; Yang H.-C.; Lin P.-Y.; Yen T.-C.; Lin Y.-W.; Wang J.-H.; Raghav L.; Lin C.-Y.; Chen Y.-S.; Wu P.-S.; Lai C.-T.; Weng S.-H.; Su K.-Y.; Chang W.-H.; Tsai P.-Y.; Robles A.I.; Rodriguez H.; Hsiao Y.-J.; Chang W.-H.; Sung T.-Y.; Chen J.-S.; Yu S.-L.; Choudhary J.S.; Chen H.-Y.; Yang P.-C.; Chen Y.-J. |
| 臺大學術典藏 |
2022-02-14T07:10:40Z |
Pulmonary pleomorphic carcinoma with pembrolizumab monotherapy
|
Chang H.-C.; Hsu C.-L.; YIH-LEONG CHANG; Yu C.-J. |
| 臺大學術典藏 |
2022-02-14T07:10:40Z |
Association of Programmed Death-Ligand 1 Expression with Fusion Variants and Clinical Outcomes in Patients with Anaplastic Lymphoma Kinase-Positive Lung Adenocarcinoma Receiving Crizotinib
|
Yang C.-Y.; Liao W.-Y.; Ho C.-C.; Chen K.-Y.; Tsai T.-H.; Hsu C.-L.; Liu Y.-N.; Su K.-Y.; YIH-LEONG CHANG; Wu C.-T.; Liao B.-C.; Hsu C.-C.; Hsu W.-H.; Lee J.-H.; Lin C.-C.; Shih J.-Y.; Yang J.C.-H.; Yu C.-J. |
| 臺大學術典藏 |
2022-02-14T07:10:40Z |
Monocarboxylate Transporter 4 Is a Therapeutic Target in Non-small Cell Lung Cancer with Aerobic Glycolysis Preference
|
Kuo T.-C.; Huang K.-Y.; Yang S.-C.; Wu S.; Chung W.-C.; YIH-LEONG CHANG; Hong T.-M.; Wang S.-P.; Chen H.-Y.; Hsiao T.-H.; Yang P.-C. |
| 臺大學術典藏 |
2022-02-14T07:10:39Z |
Multi-kinase framework promotes proliferation and invasion of lung adenocarcinoma through activation of dynamin-related protein 1
|
Chung K.-P.; Huang Y.-L.; Chen Y.-J.; Juan Y.-H.; Hsu C.-L.; Nakahira K.; Huang Y.-T.; Lin M.-W.; Wu S.-G.; Shih J.-Y.; YIH-LEONG CHANG; Yu C.-J. |
| 臺大學術典藏 |
2022-02-14T07:10:39Z |
The differences of immunologic and TP53 mutant phenotypes between synchronous and metachronous head and neck cancer and esophageal cancer
|
Chen T.-C.; Wu C.-T.; Wang C.-P.; Lou P.-J.; Ko J.-Y.; YIH-LEONG CHANG |
| 臺大學術典藏 |
2022-02-14T07:10:39Z |
Loss of SFRP1 expression is a key progression event in gastrointestinal stromal tumor pathogenesis
|
Liang C.-W.; Yang C.-Y.; Flavin R.; Fletcher J.A.; Lu T.-P.; Lai I.-R.; Li Y.-I.; YIH-LEONG CHANG; Lee J.-C. |
| 臺大學術典藏 |
2022-02-14T07:10:38Z |
Vorinostat combined with brigatinib overcomes acquired resistance in EGFR-C797S-mutated lung cancer
|
Lin C.-Y.; Huang K.-Y.; Lin Y.-C.; Yang S.-C.; Chung W.-C.; YIH-LEONG CHANG; Shih J.-Y.; Ho C.-C.; Lin C.-A.; Shih C.-C.; Chang Y.-H.; Kao S.-H.; Yang P.-C. |
| 臺大學術典藏 |
2022-01-15T00:07:47Z |
Incidence and prognostic significance of extranodal extension in isolated nodal recurrence of oral squamous cell carcinoma
|
Chang, Chun Wei; Wang, Chi; Lu, Chi Ju; CHUN-WEI WANG; CHEN-TU WU; CHENG-PING WANG; TSUNG-LIN YANG; PEI-JEN LOU; Ko, Jenq Yuh; YIH-LEONG CHANG; TSENG-CHENG CHEN |
| 臺大學術典藏 |
2021-07-15T05:31:52Z |
Vorinostat combined with brigatinib overcomes acquired resistance in EGFR-C797S-mutated lung cancer
|
Lin, Chia Yi; Huang, Kuo Yen; Lin, Yi Chun; Yang, Shuenn Chen; Chung, Wei Chia; YIH-LEONG CHANG; JIN-YUAN SHIH; CHAO-CHI HO; Lin, Chih An; Shih, Chih Chun; Chang, Ya Hsuan; Kao, Shih Han; PAN-CHYR YANG |
